580 related articles for article (PubMed ID: 30828332)
21. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.
Bernink JH; Peters CP; Munneke M; te Velde AA; Meijer SL; Weijer K; Hreggvidsdottir HS; Heinsbroek SE; Legrand N; Buskens CJ; Bemelman WA; Mjösberg JM; Spits H
Nat Immunol; 2013 Mar; 14(3):221-9. PubMed ID: 23334791
[TBL] [Abstract][Full Text] [Related]
22. Vitamins A and D have antagonistic effects on expression of effector cytokines and gut-homing integrin in human innate lymphoid cells.
Ruiter B; Patil SU; Shreffler WG
Clin Exp Allergy; 2015 Jul; 45(7):1214-25. PubMed ID: 25959810
[TBL] [Abstract][Full Text] [Related]
23. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.
Wang SC; Yang KD; Lin CY; Huang AY; Hsiao CC; Lin MT; Tsai YG
Pediatr Blood Cancer; 2020 Feb; 67(2):e28075. PubMed ID: 31736241
[TBL] [Abstract][Full Text] [Related]
24. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
[TBL] [Abstract][Full Text] [Related]
25. Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer.
Calvi M; Di Vito C; Frigo A; Trabanelli S; Jandus C; Mavilio D
Front Immunol; 2022; 13():914266. PubMed ID: 35720280
[TBL] [Abstract][Full Text] [Related]
26. Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation.
Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Höög C; Friberg D; Mjösberg J
Eur J Immunol; 2019 Sep; 49(9):1344-1355. PubMed ID: 31151137
[TBL] [Abstract][Full Text] [Related]
27. Dissecting human ILC heterogeneity: more than just three subsets.
Simoni Y; Newell EW
Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
[TBL] [Abstract][Full Text] [Related]
28. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.
Silver JS; Kearley J; Copenhaver AM; Sanden C; Mori M; Yu L; Pritchard GH; Berlin AA; Hunter CA; Bowler R; Erjefalt JS; Kolbeck R; Humbles AA
Nat Immunol; 2016 Jun; 17(6):626-35. PubMed ID: 27111143
[TBL] [Abstract][Full Text] [Related]
30. Maintenance of Immune Homeostasis through ILC/T Cell Interactions.
von Burg N; Turchinovich G; Finke D
Front Immunol; 2015; 6():416. PubMed ID: 26322047
[TBL] [Abstract][Full Text] [Related]
31. ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients.
Eken A; Cansever M; Okus FZ; Erdem S; Nain E; Azizoglu ZB; Haliloglu Y; Karakukcu M; Ozcan A; Devecioglu O; Aksu G; Arikan Ayyildiz Z; Topal E; Karakoc Aydiner E; Kiykim A; Metin A; Cipe F; Kaya A; Artac H; Reisli I; Guner SN; Uygun V; Karasu G; Dönmez Altuntas H; Canatan H; Oukka M; Ozen A; Chatila TA; Keles S; Baris S; Unal E; Patiroglu T
Allergy; 2020 Apr; 75(4):921-932. PubMed ID: 31596517
[TBL] [Abstract][Full Text] [Related]
32. Skin-resident innate lymphoid cells converge on a pathogenic effector state.
Bielecki P; Riesenfeld SJ; Hütter JC; Torlai Triglia E; Kowalczyk MS; Ricardo-Gonzalez RR; Lian M; Amezcua Vesely MC; Kroehling L; Xu H; Slyper M; Muus C; Ludwig LS; Christian E; Tao L; Kedaigle AJ; Steach HR; York AG; Skadow MH; Yaghoubi P; Dionne D; Jarret A; McGee HM; Porter CBM; Licona-Limón P; Bailis W; Jackson R; Gagliani N; Gasteiger G; Locksley RM; Regev A; Flavell RA
Nature; 2021 Apr; 592(7852):128-132. PubMed ID: 33536623
[TBL] [Abstract][Full Text] [Related]
33. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.
Cella M; Gamini R; Sécca C; Collins PL; Zhao S; Peng V; Robinette ML; Schettini J; Zaitsev K; Gordon W; Bando JK; Yomogida K; Cortez V; Fronick C; Fulton R; Lin LL; Gilfillan S; Flavell RA; Shan L; Artyomov MN; Bowman M; Oltz EM; Jelinsky SA; Colonna M
Nat Immunol; 2019 Aug; 20(8):980-991. PubMed ID: 31209406
[TBL] [Abstract][Full Text] [Related]
34. Polychromic Reporter Mice Reveal Unappreciated Innate Lymphoid Cell Progenitor Heterogeneity and Elusive ILC3 Progenitors in Bone Marrow.
Walker JA; Clark PA; Crisp A; Barlow JL; Szeto A; Ferreira ACF; Rana BMJ; Jolin HE; Rodriguez-Rodriguez N; Sivasubramaniam M; Pannell R; Cruickshank J; Daly M; Haim-Vilmovsky L; Teichmann SA; McKenzie ANJ
Immunity; 2019 Jul; 51(1):104-118.e7. PubMed ID: 31128961
[TBL] [Abstract][Full Text] [Related]
35. Age-Related Dynamics of Circulating Innate Lymphoid Cells in an African Population.
Darboe A; Nielsen CM; Wolf AS; Wildfire J; Danso E; Sonko B; Bottomley C; Moore SE; Riley EM; Goodier MR
Front Immunol; 2020; 11():594107. PubMed ID: 33343571
[TBL] [Abstract][Full Text] [Related]
36. Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung.
De Grove KC; Provoost S; Verhamme FM; Bracke KR; Joos GF; Maes T; Brusselle GG
PLoS One; 2016; 11(1):e0145961. PubMed ID: 26727464
[TBL] [Abstract][Full Text] [Related]
37. Increased circulating innate lymphoid cell (ILC)1 and decreased circulating ILC3 are involved in the pathogenesis of Henoch-Schonlein purpura.
Zhang L; Lin Q; Jiang L; Wu M; Huang L; Quan W; Li X
BMC Pediatr; 2022 Apr; 22(1):201. PubMed ID: 35413831
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.
Bernink JH; Krabbendam L; Germar K; de Jong E; Gronke K; Kofoed-Nielsen M; Munneke JM; Hazenberg MD; Villaudy J; Buskens CJ; Bemelman WA; Diefenbach A; Blom B; Spits H
Immunity; 2015 Jul; 43(1):146-60. PubMed ID: 26187413
[TBL] [Abstract][Full Text] [Related]
39. Innate lymphoid cells exhibited IL-17-expressing phenotype in active tuberculosis disease.
Pan L; Chen X; Liu X; Qiu W; Liu Y; Jiang W; Zheng Y; Mou Y; Xu W; Li X; Ge H; Zhu H
BMC Pulm Med; 2021 Oct; 21(1):318. PubMed ID: 34641843
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.
Klose CSN; Flach M; Möhle L; Rogell L; Hoyler T; Ebert K; Fabiunke C; Pfeifer D; Sexl V; Fonseca-Pereira D; Domingues RG; Veiga-Fernandes H; Arnold SJ; Busslinger M; Dunay IR; Tanriver Y; Diefenbach A
Cell; 2014 Apr; 157(2):340-356. PubMed ID: 24725403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
